Novartis/fda Crada Qbd Project – Real Life Case Studies of Qbd Applied to Active Pharmaceutical Ingredient and Drug Product Manufacturing Processes

Tuesday, November 18, 2008: 8:55 AM
Room 109-B (Pennsylvania Convention Center)

Marc Goeller, Global PAT, Novartis, East Hanover, NJ

Since 2006, teams from Novartis Pharmaceuticals Corp. and the FDA's Division of Product Quality Research have been collaborating through a Cooperative Research and Development Agreement (CRADA) on the implementation of Quality by Design principles to the API and Drug Product manufacturing processes of a commercial product. This presentation will therefore consist of case studies extracted from this pilot project and will also highlight the key lessons learned.
Extended Abstract: File Not Uploaded